Find Federal Grants
Rapid Assessment of Drug Abuse: Smart City Tools (R41/R42 - Clinical Trial Optional)
National Institutes of Health · RFA-DA-20-020
Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)
National Institutes of Health · PAR-19-282
MARAD Maritime Internship
National Park Service · P19AS00158
National Park Service · NPS-19-NERO-0018
Bosnia USAID-Herzegovina · 72016819RFA00003
Office of Postsecondary Education (OPE): Developing Hispanic-Serving Institutions Program CFDA Number 84.031S
Department of Education · ED-GRANTS-051519-001
EONS 2019: Appendix H MUREP Aerospace High-Volume Manufacturing and Supply Chain Management Cooperative Agreement
National Aeronautics and Space Administration · NNH18ZHA008C-MUREPARMD
National Park Service · P19AS00155
Planning Grant for Fogarty HIV Research Training Program for Low- and Middle-Income Country Institutions (D71 Clinical Trial Not Allowed)
National Institutes of Health · PAR-19-284
Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43 Clinical Trial Optional)
National Institutes of Health · PAR-19-283
Infrastructure Development Training Programs for Critical HIV Research at Low-and Middle-Income Country Institutions (G11 Clinical Trials Not Allowed)
National Institutes of Health · PAR-19-285
Fiscal Year (FY) 2019 Homeland Security National Training Program (HSNTP) - National Domestic Preparedness Consortium (NDPC)
Department of Homeland Security - FEMA · DHS-19-NPD-005-00-03
Digital Health Technologies to Address the Social Determinants of Health in context of Substance Use Disorders (SUD) (R43/R44 Clinical Trial Optional)
National Institutes of Health · RFA-DA-20-018
Digital Health Technologies to Address the Social Determinants of Health in context of Substance Use Disorders (SUD) (R41/R42 Clinical Trial Optional)
National Institutes of Health · RFA-DA-20-017
Provocative Questions (PQs) in Multiple Myeloma Disparities Research (R21 Clinical Trial Optional)
National Institutes of Health · PAR-19-280
2019 TV CO-OP
U.S. Mission to Georgia · DOS-GEO-19-CA-002-051319
Provocative Questions (PQs) in Multiple Myeloma Disparities Research (R01 Clinical Trial Optional)
National Institutes of Health · PAR-19-279
Bureau of Justice Assistance · BJA-2019-15319
National Park Service · NPS-19-NERO-0023
Exploiting Genome or Epigenome Editing to Functionally Validate Genes or Variants Involved in Substance Use Disorders (R21/R33 Clinical Trial Not Allowed)
National Institutes of Health · PAR-19-278